Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CTT Pharmaceutical Holdings Inc CTTH

Healthcare Biotechnology
CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. The Company's technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. The Wafer rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. VetWafe is used for pain management for the pet markets. This product is thin films for treating dogs and cats.


OTCPK:CTTH - Post by User

CTT Pharmaceutical Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Post by markenurhon Oct 04, 2022 4:03pm
111 Views
Post# 35005037

CEO Issues Letter To Shareholders

CEO Issues Letter To Shareholdershttps://www.thenewswire.com/press-releases/1k98Fwvvm-ctt-pharmas-ceo-issues-letter-to-shareholders.html
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities